Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fred Mermelstein


Mr. Fred Mermelstein serves as President at Javelin Pharmaceuticals. He is an Angel Investor. He completed his post-doctoral training supported by two grant awards; a National Institutes of Health fellowship and a Howard Hughes Medical Institute fellowship in the Department of Biochemistry at UMDNJ Robert Wood Johnson Medical School.

Primary Investor Type
Angel (individual)
Primary Office
  • 125 CambridgePark Drive
  • Cambridge, MA 02140
  • United States

Fred Mermelstein Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00 00000000000 27-May-2016 00000 00000 00000 Surgical Devices Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fred Mermelstein’s full profile, request a free trial.

Fred Mermelstein Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 00000000000 30-Apr-2018 0000000000 Completed
  • 2 buyers
To view this investor’s complete exits history, request access »

Fred Mermelstein Team (1)

Name Title Deals Funds Boards Office Contact
Fred Mermelstein Ph.D Angel Investor Cambridge, MA

Fred Mermelstein Co-Investors (2)

Name With Exits Lead Partner
Alpine Meridian 1 0
Ulrich Kosciessa 0 0
To view this investor’s complete co-investor history, request access »